(Q39408073)

11 September 2017

title

What do patients with migraine want from acute migraine treatment? (English)

1 reference

11 September 2017

0 references

1 reference

Richard B Lipton

1 reference

11 September 2017

Sandra W Hamelsky

1 reference

11 September 2017

Jeffrey M Dayno

series ordinal

1 reference

11 September 2017

language of work or name

1 reference

1 January 2002

1 reference

11 September 2017

1 reference

11 September 2017

volume

42 Suppl 1

1 reference

11 September 2017

page(s)

3-9

1 reference

Diagnosis and treatment of migraine

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

The burden of migraine. A review of cost to society

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

Prevalence and impact of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

Migraine diagnosis and treatment: results from the American Migraine Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

Burden of migraine: societal costs and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

Burden of migraine in the United States: disability and economic costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

Migraine and reduced work performance: a population-based diary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

Migraine, quality of life, and depression: a population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

The impact of migraine on quality of life in the general population: the GEM study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

Acute migraine treatment outcome measures: a clinician's view

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

Determinants of patient satisfaction with migraine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

Burden of migraine. A review of its socioeconomic impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.0420S1003.X

10.1046/J.1526-4610.2002.0420S1003.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference